Paper4563045
1,3-bis(2-chloroethyl)-1-nitrosourea (bcnu) and other nitrosoureas in cancer treatment: a review.
Carter SK and 3 others. Adv Cancer Res, 1972. Cited by 104 papers, by iCite.
Cite this record
ConductScience Library. 1,3-bis(2-chloroethyl)-1-nitrosourea (bcnu) and other nitrosoureas in cancer treatment: a review. Papers, record 4563045. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4563045
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- 1,3-bis(2-chloroethyl)-1-nitrosourea (bcnu) and other nitrosoureas in cancer treatment: a review.
- PubMed
Topics25
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Carmustine | Major topic |
| Neoplasms | Major topic |
| Nitrosourea Compounds | Major topic |
| Adenocarcinoma | |
| Animals | |
| Carcinoma | |
| Cell Line | |
| Cell-Free System | |
| Chemical Phenomena | |
| Chemistry | |
| Clinical Trials as Topic | |
| Cricetinae | |
| Humans | |
| Leukemia L1210 | |
| Lung Neoplasms | |
| Mice | |
| Mice, Inbred Strains | |
| National Institutes of Health (U.S.) | |
| Neoplasm Transplantation | |
| Neoplasms, Experimental | |
| Rats | |
| Sarcoma, Experimental | |
| Structure-Activity Relationship | |
| United States |
Source PubMed
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 104 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37612719 | A multi-functional hypoxia/esterase dual stimulus responsive and hyaluronic acid-based nanomicelle for targeting delivery of chloroethylnitrosouea. | J Nanobiotechnology | 2023 | https://conductscience.org/library/papers/37612719 | PubMed |
| 27471070 | Concurrent Chemotherapy of Malignant Glioma in Rats by Using Multidrug-Loaded Biodegradable Nanofibrous Membranes. | Sci Rep | 2016 | https://conductscience.org/library/papers/27471070 | PubMed |
| 21380568 | HPLC method validation for the quantification of lomustine to study pharmacokinetics of thermosensitive liposome-encapsulated lomustine containing iohexol for CT imaging in C6 glioma rats. | Eur J Drug Metab Pharmacokinet | 2011 | https://conductscience.org/library/papers/21380568 | PubMed |
| 18472995 | Interstitial chemotherapy with biodegradable BCNU (Gliadel) wafers in the treatment of malignant gliomas. | Ther Clin Risk Manag | 2007 | https://conductscience.org/library/papers/18472995 | PubMed |
| 11349876 | Antitumor efficacy of SarCNU in a human glioma xenograft model expressing both MGMT and extraneuronal monoamine transporter. | J Neurooncol | 2001 | https://conductscience.org/library/papers/11349876 | PubMed |
| 10582663 | Enhanced antitumor activity of sarCNU in comparison to BCNU in an extraneuronal monoamine transporter positive human glioma xenograft model. | J Neurooncol | 1999 | https://conductscience.org/library/papers/10582663 | PubMed |
| 8552605 | Increasing DNA repair methyltransferase levels via bone marrow stem cell transduction rescues mice from the toxic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea, a chemotherapeutic alkylating agent. | Proc Natl Acad Sci U S A | 1996 | https://conductscience.org/library/papers/8552605 | PubMed |
| 8507720 | MCNU in the treatment of essential thrombocythemia--a pilot study. | Ann Hematol | 1993 | https://conductscience.org/library/papers/8507720 | PubMed |
| 8500228 | Effect of O6-benzylguanine on the response to 1,3-bis(2-chloroethyl)-1-nitrosourea in the Dunning R3327G model of prostatic cancer. | Cancer Chemother Pharmacol | 1993 | https://conductscience.org/library/papers/8500228 | PubMed |
| 8226282 | Enhanced antitumor activity and reduced toxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea administered in lipid microspheres to tumor-bearing mice. | Jpn J Cancer Res | 1993 | https://conductscience.org/library/papers/8226282 | PubMed |
| 7002528 | Cancer chemotherapy: new developments and changing concepts. | Drugs | 1980 | https://conductscience.org/library/papers/7002528 | PubMed |
| 6954016 | Treatment of patients with refractory myelogenous leukemia with BCOMM[1,3-bis-chloro(2-chloroethyl)-1-nitrosourea (BCNU), oncovin (vincristine), cyclophosphamide, high-dose methotrexate and methyl-glyoxal bis-guanylhydrazone (MGBG)]. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/6954016 | PubMed |
| 6852549 | Histopathologic changes following carmustine treatment of uveal Greene melanoma in rabbits. | Graefes Arch Clin Exp Ophthalmol | 1983 | https://conductscience.org/library/papers/6852549 | PubMed |
| 6603303 | Difference in effect of single immunosuppressive agents (cyclophosphamide, CCNU, 5-FU) on peripheral blood immune cell parameters and central nervous system immunoglobulin synthesis rate in patients with multiple sclerosis. | Clin Exp Immunol | 1983 | https://conductscience.org/library/papers/6603303 | PubMed |
| 6235230 | The level of DNA interstrand crosslinking in bone marrow parallels the extent of myelosuppression in mice treated with four chloroethylnitrosoureas. | J Cancer Res Clin Oncol | 1984 | https://conductscience.org/library/papers/6235230 | PubMed |
| 6222844 | Antitumor effects of GANU and other nitrosourea derivatives against transplantable leukemias and solid tumors in mice. | Cancer Chemother Pharmacol | 1983 | https://conductscience.org/library/papers/6222844 | PubMed |
| 6189661 | Clinical pharmacokinetics of commonly used anticancer drugs. | Clin Pharmacokinet | 1983 | https://conductscience.org/library/papers/6189661 | PubMed |
| 4085418 | Repair of O6-(2-chloroethyl)guanine mediates the biological effects of chloroethylnitrosoureas. | Environ Health Perspect | 1985 | https://conductscience.org/library/papers/4085418 | PubMed |
| 4077917 | Relationship between DNA damage and the inhibition of stem cells in murine bone marrow after single and repeated administration of BCNU and HECNU. | J Cancer Res Clin Oncol | 1985 | https://conductscience.org/library/papers/4077917 | PubMed |
| 3949853 | Comparison of DNA damage in various tissues, myelosuppression and serum levels of transaminases and bilirubin in tumor-bearing female Sprague-Dawley rats treated with 1-(2-hydroxyethyl)-3-(2-chloroethyl)-3-nitrosourea (HECNU). | J Cancer Res Clin Oncol | 1986 | https://conductscience.org/library/papers/3949853 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4563045
GET https://conductscience.org/api/papers/v1/4563045/cited_by?page=2